Castleark Management’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-68,708
Closed -$5.43M 341
2021
Q3
$5.43M Sell
68,708
-3,853
-5% -$310K 0.21% 117
2021
Q2
$5.72M Sell
72,561
-84,457
-54% -$6.47M 0.19% 132
2021
Q1
$11.8M Buy
157,018
+44,499
+40% +$3.26M 0.43% 64
2020
Q4
$7.41M Sell
112,519
-82,461
-42% -$4.82M 0.28% 99
2020
Q3
$10.5M Sell
194,980
-834
-0.4% -$45.8K 0.41% 62
2020
Q2
$9.4M Buy
195,814
+29,692
+18% +$1.31M 0.41% 59
2020
Q1
$5.66M Sell
166,122
-5,502
-3% -$302K 0.34% 84
2019
Q4
$10.7M Buy
+171,624
New +$9.7M 0.43% 60
2017
Q4
Sell
-45,890
Closed -$3.29M 415
2017
Q3
$3.29M Buy
+45,890
New +$3.19M 0.1% 224
2016
Q3
Sell
-172,766
Closed -$7.87M 392
2016
Q2
$7.87M Sell
172,766
-3,175
-2% -$155K 0.25% 119
2016
Q1
$8.66M Buy
+175,941
New +$7.48M 0.27% 95

Other funds holding ENOV

Castleark Management's ENOV Position: Q4 2021 in Review

Castleark Management sold out of Enovis (ENOV) in Q4 2021, closing a stake of 68,708 shares — an estimated $5.43M sold.

Castleark Management first reported a position in ENOV in Q1 2016 and held it in 11 quarters. The position peaked at $11.8M in Q1 2021. 314 funds tracked by Wall St. Rank hold ENOV as of Q4 2021.

  • Castleark Management reported no remaining Enovis position as of Q4 2021 after selling out during the quarter.
  • Castleark Management sold 68,708 Enovis shares in Q4 2021, an estimated $5.43M.
  • Castleark Management first reported a position in Enovis in Q1 2016 and held it in 11 quarters.
  • Castleark Management's Enovis position peaked at $11.8M in Q1 2021.
  • 314 funds tracked by Wall St. Rank held Enovis as of Q4 2021.

Based on Castleark Management's 13F filing for Q4 2021, filed 16 Feb 2022.